TMONYSEMeasuring & Controlling Devices, NECFiscal year ends December 31
THERMO FISHER SCIENTIFIC INC.
Financials through Q2 FY2026, quarter ended Jun 27, 2026Last filing: 10-Q on Jul 31, 2026
$679.38−10.62 (-1.54%)
Close on Oct 19, 2026
- Market cap
- $252.05B
- P/E (TTM)
- 36.6
- Dividend yield
- 0.25%
Thermo Fisher Scientific statistics
Financials through Jun 27, 2026, price as of Oct 19, 2026, median of Measuring & Controlling Devices, NEC companies for comparison
Valuation
| Measure | Thermo Fisher Scientific | Industry median |
|---|---|---|
| Market Cap | $251.20B | $229.23M |
| Enterprise Value | $289.69B | $194.73M |
| PE Ratio | 36.57 | 33.41 |
| PS Ratio | 5.42 | 3.14 |
| PB Ratio | 4.77 | 3.19 |
| P/FCF Ratio | 34.33 | 27.25 |
| P/OCF Ratio | 27.87 | 22.23 |
Enterprise value
| Measure | Thermo Fisher Scientific | Industry median |
|---|---|---|
| EV / Sales | 6.25 | 2.93 |
| EV / EBITDA | 35.56 | 19.97 |
| EV / EBIT | 35.56 | 25.47 |
| EV / FCF | 39.59 | 27.85 |
Income (trailing twelve months)
| Measure | Thermo Fisher Scientific | Industry median |
|---|---|---|
| Revenue | $46.34B | $102.39M |
| Operating Income | $8.15B | -$4.31M |
| Pretax Income | $7.64B | -$2.26M |
| Net Income | $6.97B | -$6.57M |
| EBITDA | $8.15B | -$1.98M |
| EPS (Diluted) | $18.58 | -$0.07 |
Margins
| Measure | Thermo Fisher Scientific | Industry median |
|---|---|---|
| Operating Margin | 17.6% | -6.04% |
| Pretax Margin | 16.5% | -4.11% |
| Profit Margin | 15.0% | -10.5% |
| EBITDA Margin | 17.6% | -2.67% |
| FCF Margin | 15.8% | -0.30% |
Returns
| Measure | Thermo Fisher Scientific | Industry median |
|---|---|---|
| Return on Equity (ROE) | 13.5% | -19.2% |
| Return on Assets (ROA) | 6.50% | -13.3% |
| Return on Invested Capital (ROIC) | 8.81% | -4.11% |
| Return on Capital Employed (ROCE) | 8.30% | -9.07% |
Growth
| Measure | Thermo Fisher Scientific | Industry median |
|---|---|---|
| Revenue Growth (YoY) | 7.23% | 8.85% |
| Net Income Growth (YoY) | 5.82% | 10.6% |
| EPS Growth (YoY) | 7.46% | 10.6% |
| FCF Growth (YoY) | 18.6% | 10.6% |
| Revenue Growth (3Y CAGR) | -0.27% | 7.08% |
| Revenue Growth (5Y CAGR) | 6.70% | 11.8% |
| EPS Growth (3Y CAGR) | 0.21% | 3.06% |
| EPS Growth (5Y CAGR) | 2.14% | 7.64% |
Balance sheet
| Measure | Thermo Fisher Scientific | Industry median |
|---|---|---|
| Cash & Short-Term Investments | $4.06B | $37.33M |
| Total Debt | $42.55B | $72.66M |
| Net Cash (Debt) | -$38.49B | $3.92M |
| Net Cash Per Share | -$104.08 | $0.28 |
| Equity (Book Value) | $52.68B | $57.36M |
| Book Value Per Share | $142.47 | $2.81 |
| Tangible Book Value | -$20.76B | $10.71M |
| Working Capital | $8.30B | $54.64M |
Financial position
| Measure | Thermo Fisher Scientific | Industry median |
|---|---|---|
| Current Ratio | 1.55 | 2.50 |
| Quick Ratio | 0.90 | 1.54 |
| Debt / Equity | 0.81 | 0.38 |
| Debt / EBITDA | 5.22 | 2.31 |
| Debt / FCF | 5.81 | 3.50 |
| Net Debt / EBITDA | 4.72 | 1.53 |
| Interest Coverage | 5.55 | -1.81 |
Cash flow (trailing twelve months)
| Measure | Thermo Fisher Scientific | Industry median |
|---|---|---|
| Operating Cash Flow | $9.01B | -$653.46K |
| Capital Expenditures | -$1.70B | -$3.69M |
| Free Cash Flow | $7.32B | -$835.02K |
| FCF Per Share | $19.79 | -$0.02 |
Efficiency
| Measure | Thermo Fisher Scientific | Industry median |
|---|---|---|
| Asset Turnover | 0.43 | 0.59 |
| Revenue Per Employee | $370.69K | $322.75K |
| Profits Per Employee | $55.74K | -$52.11K |
| Employee Count | 125,000 | 197 |
Dividends and yields
| Measure | Thermo Fisher Scientific | Industry median |
|---|---|---|
| Earnings Yield | 2.77% | -6.92% |
| FCF Yield | 2.91% | -0.62% |
| Dividend Yield | 0.25% | 0.81% |
| Buyback Yield | 1.99% | 0.78% |
| Shareholder Yield | 2.24% | 0.84% |
| Dividend Per Share | $1.72 | $0.72 |
| Dividend Growth (YoY) | 10.3% | 4.80% |
| Years of Dividend Growth | 8 | 0 |
| Payout Ratio | 9.50% | 30.3% |
| FCF Payout Ratio | 9.05% | 21.9% |
Shares
| Measure | Thermo Fisher Scientific | Industry median |
|---|---|---|
| Shares Outstanding | 369,747,000 | 44,856,700 |
| Shares Change (YoY) | -1.57% | 3.35% |
| Float | 369,250,000 | 36,934,400 |
| Shares Held by Insiders | 0.13% | 10.6% |
| Shares Held by Institutions | 90.9% | 63.5% |
Taxes
| Measure | Thermo Fisher Scientific | Industry median |
|---|---|---|
| Income Tax | $597.00M | $1.52M |
| Effective Tax Rate | 7.82% | 18.6% |
Scores
| Measure | Thermo Fisher Scientific | Industry median |
|---|---|---|
| Graham Number | $244.05 | $34.37 |
| Graham Upside | -64.1% | -58.3% |
| Altman Z-Score | 4.00 | 1.95 |
| Piotroski F-Score | 6 | 5 |
Calculated by StockData from Thermo Fisher Scientific's SEC filings and the latest closing price. Hover a measure to see its formula. The grey column is the median of companies in the same industry group (two-digit SIC code); green or red marks a better or worse value than that median.